HealthStream, Inc. (NASDAQ:HSTM) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts. Canaccord Notes HealthStream, Inc. (HSTM) Well-Positioned Amid Rising AI Pressures on Software Firms HealthStream, Inc. (NASDAQ:HSTM) is next on our list of most promising stocks. TheFly reported on February 25 that Canaccord reduced its price target for HSTM from $25 to $21 and maintained a Hold rating. According to the firm, despite mounting investor fears about AI impacting SaaS firms, ...

Ziff Davis, Inc. (NASDAQ:ZD) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts. Ziff Davis, Inc. (ZD) Q4 Revenue Slips to $406.7M as Net Income Declines The ninth stock on this list of most promising stocks is Ziff Davis, Inc. (NASDAQ:ZD) TheFly reported on February 26 that Citigroup maintained a Neutral rating on ZD but lowered the price target to $29 from $35. On February 23, Ziff Davis, Inc. (NASDAQ:ZD) released its financial results for the fourth quarter and the ful ...

MoonLake Immunotherapeutics (NASDAQ:MLTX) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts. Goldman Questions MoonLake Immunotherapeutics' (MLTX) Sonelokimab Approval Odds Despite Pipeline Update MoonLake Immunotherapeutics (NASDAQ:MLTX) is placed eighth on our list of most promising stocks. TheFly reported on February 26 that Goldman Sachs increased its price target on MLTX to $11 from $10 and maintained a Sell rating. The update followed the company’s fourth-quarter an ...

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts. Wells Fargo Sees Amphastar Pharmaceuticals, Inc.'s (AMPH) AMP-007 as Key to Mid- to High-Single-Digit Growth The seventh stock among the small-cap stocks is Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH). TheFly reported on February 27 that Wells Fargo reduced its price target on AMPH to $30 from $34 and kept an Overweight rating on the shares. Despite the recent approvals of A ...

Marqeta, Inc. (NASDAQ:MQ) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts. Marqeta, Inc. (MQ) Labeled 'Show-Me' Story After Q4 Report, Says Morgan Stanley Marqeta, Inc. (NASDAQ:MQ) is placed sixth among the most promising stocks on our list. TheFly reported on February 25 that Morgan Stanley reduced its price target for MQ to $5 from $6 while keeping an Equal Weight rating on the shares. The firm emphasized that after the Q4 report, it still views MQ as a "show-me" comp ...

Willdan Group, Inc. (NASDAQ:WLDN) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts. Willdan Group, Inc. (WLDN) Selected for $49M Energy Services Project at Mt. San Antonio College The fifth stock is Willdan Group, Inc. (NASDAQ:WLDN) on this list. TheFly reported on February 27 that WLDN announced it was chosen by Mt. San Antonio College in California to carry out a $49 million energy services project. In addition to infrastructure upgrades like solar photovoltaic install ...

The Marcus Corporation (NYSE:MCS) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts. The Marcus Corporation (MCS) Reports Improved Profitability for Fiscal 2025 Another one of the most promising stocks on our list is The Marcus Corporation (NYSE:MCS). TheFly reported on Feb 26 that MCS reported its fourth-quarter and full-year fiscal 2025 results. The report states that while operational income was $1.7 million as opposed to a $2.2 million loss in the previous year, the c ...

Forward Air Corporation (NASDAQ:FWRD) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts. Forward Air Corporation (FWRD) Seen as Attractive Value at 8.5x 2026 EBITDA, Says Susquehanna Forward Air Corporation (NASDAQ:FWRD) is among the most promising stocks. TheFly reported on February 24 that Susquehanna lowered FWRD price target to $42 from $45 and maintained a Positive rating on the shares. With shares trading at about 8.5 times estimated 2026 EBITDA, the stock continues ...

Core Insights - Fortrea Holdings Inc. (NASDAQ:FTRE) is recognized as one of the most promising small-cap stocks by Wall Street analysts [1] - The company has provided financial guidance for 2026, projecting total revenues between $2,550 million and $2,650 million, with adjusted EBITDA expected to range from $190 million to $220 million [4][6] Financial Performance - For Q4 2025, Fortrea reported sales of $660.5 million, while the total sales for the entire year reached $2,723.4 million [5] - The company experienced a GAAP net loss of $(986.2) million, primarily due to a $797.9 million non-cash goodwill impairment, although adjusted net income was reported at $40.4 million [5] - The adjusted EBITDA for 2025 was $189.9 million, and the company ended the year with $174.6 million in cash and cash equivalents, alongside $1,066.3 million in gross debt [5] Market Position - Fortrea Holdings operates as a global contract research organization, providing a range of services including clinical development, trial management, pharmacology, and consulting to pharmaceutical, biotech, and medical device companies [7]

Armata Pharmaceuticals, Inc. (NYSEAM:ARMP) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts. H.C. Wainwright Reaffirms Buy on Armata Pharmaceuticals, Inc. (ARMP) After FDA Nod Armata Pharmaceuticals, Inc. (NYSEAM:ARMP) is among the most promising stocks. On February 23, 2026, H.C. Wainwright increased the price target for ARMP from $9.00 to $15.00 and kept a Buy rating on the shares. The modification comes after the FDA designated AP-SA02 as a Qualified Infectious Diseas ...